» Authors » Laura Milazzo

Laura Milazzo

Explore the profile of Laura Milazzo including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 109
Citations 1205
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
21.
Antinori S, Cossu M, Ridolfo A, Rech R, Bonazzetti C, Pagani G, et al.
Pharmacol Res . 2020 May; 158:104899. PMID: 32407959
SARS-CoV-2 is causing an increasing number of deaths worldwide because no effective treatment is currently available. Remdesivir has shown in vitro activity against coronaviruses and is a possible antiviral treatment...
22.
Cattaneo D, Sollima S, Meraviglia P, Milazzo L, Minisci D, Fusi M, et al.
Drugs R D . 2020 Mar; 20(2):155-160. PMID: 32189238
Background And Objectives: Liver transplantation is now considered a safe procedure in patients with HIV because of the advent of potent antiretroviral therapies (ART). Objective: We aimed to describe the...
23.
Antinori S, Morena V, Pagani G, Venturi G, Giacomelli A, Milazzo L, et al.
Infez Med . 2020 Mar; 28(1):98-103. PMID: 32172268
Dengue fever is a mosquito-borne infection that co-circulates with Chikungunya and Zika virus infection in many parts of the world. Dengue virus (DENV) is occasionally responsible for acute hepatitis and...
24.
Milazzo L, van den Bogaart L, Sollima S, Oreni L, Lai A, Morena V, et al.
Eur J Intern Med . 2020 Jan; 75:50-54. PMID: 31980330
Background: chronic viral infections by both HCV and HIV may lead to polyclonal activation of B cells resulting in hypergammaglobulinemia. This study retrospectively analyzed the effect of HCV eradication with...
25.
Calvaruso V, Mazzarelli C, Milazzo L, Badia L, Pasulo L, Guaraldi G, et al.
Sci Rep . 2019 Jan; 9(1):585. PMID: 30679515
We reported the efficacy and safety data for daclatasvir (DCV)-based all-oral antiviral therapy in patients treated in the Italian compassionate-use program. 275 patients were included (202 male-73.5%, mean age: 57.4...
26.
Pezzani M, Di Cristo V, Parravicini C, Sonzogni A, Tonello C, Franzetti M, et al.
Travel Med Infect Dis . 2019 Jan; 31:101378. PMID: 30660554
Background: Gastrointestinal basidiobolomycosis (GIB) is a rare mycosis affecting almost exclusively immunocompetent subjects. Methods: We describe a case of GIB caused by Basidiobolus ranarum in a 25-year-old Italian immunocompetent man...
27.
Sebastiani M, Milazzo L, Atzeni F, Vacchi C, Manfredi A, Quartuccio L, et al.
Mod Rheumatol . 2018 Dec; 29(6):895-902. PMID: 30582388
The recent introduction of direct-acting antiviral agents (DAAs) which can eliminate Hepatitis C virus (HCV) had revolutionized the treatment of HCV infections also in a complex clinical setting such as...
28.
Antinori S, Napolitano M, Grande R, Passerini S, Ridolfo A, Galimberti L, et al.
Eur J Intern Med . 2018 Aug; 57:e13-e16. PMID: 30064716
No abstract available.
29.
Ferraris L, Milazzo L, Rimoldi S, Mazzali C, Barosi A, Gismondo M, et al.
Infect Dis (Lond) . 2018 May; 50(10):749-756. PMID: 29842820
Objective: Changes in the incidence, clinical features and microbiology of infective endocarditis (IE) observed in a single center in Italy were compared between the period 2003-2010 and 2011-2015. Methods: All...
30.
Ranzani A, Oreni L, Agro M, van den Bogaart L, Milazzo L, Giacomelli A, et al.
J Acquir Immune Defic Syndr . 2018 May; 78(2):193-201. PMID: 29767640
Background: As HIV-infected patients aged 50 years or older are at increased risk of comorbidities and multidrug treatments, we examined their exposure to the potential drug-drug interactions (PDDIs) of antiretroviral...